
Astraea
AI Operating System for Clinical Development
Hakkında
İngilizce şirket açıklaması
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Konular
- Konum
- San Francisco, CA, ABD
- Ekip büyüklüğü
- 6 çalışan
- YC dönemi
- Spring 2026
- Durum
- Aktif
- Aşama
- Erken aşama





